Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil commits R$1.9bn to imperilled tax-exemption regime for exporters

This article was originally published in Clinica

Executive Summary

The Brazilian government has committed R$1.9bn (US$1.1bn) to pay for a programme that exempts exporters from ICMS (Impostos Sobre Circulação de Mercadorias e Prestação de Serviços) taxes on goods and services in 2010, after previously omitting the funding from next year's federal budget. The programme entails reimbursing state and municipal authorities for the lost revenues that result from the tax-exemption scheme established by the central government – under the so-called Kandir Law – specifically to promote exports. The leading national medtech industry association, ABIMO, welcomed the development, claiming that the government of the state of São Paulo – the hub of Brazilian manufacturing – had threatened to withdraw its support for the scheme from January 1.

You may also be interested in...



Coronavirus Update: UK Calls For COVID-19 Patients To Join Trials

GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.

Manpower Not Materials Could Hold German COVID-19 Testing Back

Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.

Commission Regulatory Advice For COVID-19 Medtech Sector Entrants Amid Counterfeit Concerns

A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.

Topics

UsernamePublicRestriction

Register

MT045074

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel